WuXi XDC Cayman Inc
HKEX:2268
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
12.98
32.7
|
Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Gross Margin
WuXi XDC Cayman Inc
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Country | CN |
Market Cap | 38B HKD |
Gross Margin |
31%
|
Country | US |
Market Cap | 1.2T USD |
Gross Margin |
55%
|
Country | US |
Market Cap | 202.3B USD |
Gross Margin |
41%
|
Country | US |
Market Cap | 166.6B USD |
Gross Margin |
60%
|
Country | KR |
Market Cap | 66.8T KRW |
Gross Margin |
49%
|
Country | CH |
Market Cap | 38.4B CHF |
Gross Margin |
29%
|
Country | US |
Market Cap | 38.8B USD |
Gross Margin |
55%
|
Country | US |
Market Cap | 36.3B USD |
Gross Margin |
35%
|
Country | US |
Market Cap | 27B USD |
Gross Margin |
59%
|
Country | US |
Market Cap | 24.1B USD |
Gross Margin |
35%
|
Country | CN |
Market Cap | 162B CNY |
Gross Margin |
40%
|
WuXi XDC Cayman Inc
Glance View
WuXi XDC Cayman Inc. is an intriguing player in the biotechnology field, strategically positioned at the crossroads of innovation and precision. As a distinctive subsidiary under the umbrella of WuXi AppTec, it zeroes in on the burgeoning and highly specialized market of antibody-drug conjugates (ADCs). These ADCs are engineered to deliver chemotherapy drugs directly to cancer cells, offering a synthesis of traditional medicine's effectiveness with the pinpoint accuracy of modern biotechnology. This localized delivery aims to enhance therapeutic outcomes while minimizing adverse effects, a compelling value proposition amid rising consumer demand for more personalized cancer treatments. The company thrives through an integrated business model, presenting a suite of comprehensive services that span the entire ADC development lifecycle. It monetizes its expertise by offering clients a seamless pathway from research and development through to clinical manufacturing. Clients, which range from startup biotech firms to established pharmaceutical giants, engage WuXi XDC not only for its technical prowess but also for its capacity to expedite product pipelines. By managing complex supply chains and providing robust regulatory support, the company enables its clients to reduce time-to-market, ultimately maneuvering the intricate framework of drug development with finesse. Through this strategic approach, WuXi XDC has positioned itself as a critical partner in the ADC landscape, driving innovation and delivering value to both its clientele and stakeholders.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on WuXi XDC Cayman Inc's most recent financial statements, the company has Gross Margin of 31%.